Last reviewed · How we verify
Non-nephrotoxic antibiotics
At a glance
| Generic name | Non-nephrotoxic antibiotics |
|---|---|
| Also known as | Non-nephrotoxic antibiotics, as required |
| Sponsor | Shaare Zedek Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Folate Treatment to Reduce Death Risk in the Year After Infection-Related Acute Kidney Injury (EARLY_PHASE1)
- Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney (NA)
- Renal Impairment Associated With Colistin Levels
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-nephrotoxic antibiotics CI brief — competitive landscape report
- Non-nephrotoxic antibiotics updates RSS · CI watch RSS
- Shaare Zedek Medical Center portfolio CI